To prove that treatment of U87-MG and T98-G cells causes cell death by apoptosis and increases the levels of apoptotic markers p53 and caspase-3 while decreases the level of antiapoptotic markers (bcl2), ICC was carried out. This evidence concerns the gene BCL2 and intrahepatic cholangiocarcinoma.